Dr. Pedro Zapater Hernández
Professor of Pharmacology, Universidad Miguel Hernandez
Clinical Pharmacologist, School of Medicine, Universidad Miguel Hernández
Pharmacology, Pediatrics and Organic Chemistry
+ 34 965 91 38 96
- Nervous and immune regulation of inflammatory process.
- Inflammation and stress in the pathogenesis of cancer.
- Use of drugs in special populations: cirrhosis, pancreatitis, inflammatory bowel disease.
- Previous positions:
- Postdoctoral positions:
- PhD in Medicine.
- Degree in Medicine.
Giménez p., et al. (2018)
Liver International, DOI: 10.1111/liv.13890
Treatment with non‐selective beta‐blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis.
Roca r., et al. (2018)
Molecular Medicine Reports, DOI: 10.3892/mmr.2018.8820
β2‑adrenergic receptor functionality and genotype in two different models of chronic inflammatory disease: Liver cirrhosis and osteoarthritis.
Fuster-Lluch O., et al. (2017)
The Journal of Clinical Pharmacology, DOI: 10.1002/jcph.903
Pharmacokinetic Study of Intravenous Acetaminophen Administered to Critically Ill Multiple-Trauma Patients at the Usual Dosage and a New Proposal for Administration.
Juanola O., et al. (2016)
Liver International, DOI: 10.1111/liv.13172
Selective intestinal decontamination with norfloxacin enhances a regulatory T cell-mediated inflammatory control mechanism in cirrhosis.
Zapater P., et al. (2012)
PLoS One, DOI: 10.1371/journal.pone.0043371
Beta-Adrenergic Receptor 1 Selective Antagonism Inhibits Norepinephrine-Mediated TNF-Alpha Downregulation in Experimental Liver Cirrhosis.
- Contracts and agreements of collaboration with companies for the study of inflammation and immune response in chronic pathologies such as osteoarthritis (BIOIBERICA).